| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3979134 | Bulletin du Cancer | 2010 | 10 Pages |
Abstract
HIPEC without adjuvant chemotherapy is both feasible and safe, but with a high rate of grade 3-5 toxicity. Survival results are encouraging but should be confirmed in a randomized trial.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
N. Carrabin, F. Mithieux, P. Meeus, O. Trédan, J.-P. Guastalla, T. Bachelot, S.I. Labidi, I. Treilleux, M. Rivoire, I. Ray-Coquard,